Status:
ACTIVE_NOT_RECRUITING
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Leishmaniasis
Eligibility:
All Genders
18-70 years
Brief Summary
L. infantum leishmaniasis is endemic in the South of France. For several years, there has been an expansion of the territory of sandflies (vector of leishmaniasis), with the appearance of cases of can...
Eligibility Criteria
Inclusion
- Meet EFS blood donation criteria
- Provenance:
- Department of Alpes-Maritimes, Var and Bouches du Rhône, for the historical endemic outbreak Department of Gers, Tarn-et-Garonne and Lot for the new Occitanie household
- \- Donor who has signed genetic consent
Exclusion
- criteria for EFS blood donation
Key Trial Info
Start Date :
July 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2025
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT03784248
Start Date
July 3 2019
End Date
August 15 2025
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nice Hospital
Nice, France, 06000